论文部分内容阅读
目的:探讨CA125、CA153、TSGF三者联合检测在乳腺癌中的临床意义。方法:采用酶联免疫法检测52例乳腺癌患者及30例健康人血清CA125、CA153、TSGF水平。结果:乳腺癌患者CA125、CA153、TSGF明显高于健康人,三者联合检测阳性率明显高于任何单项检测阳性率,晚期乳腺癌患者CA125、CA153、TSGF明显高于早期患者。结论:CA125、CA153、TSGF三者联合检测对乳腺癌的早期诊断及治疗效果、预后判断有一定的意义。
Objective: To investigate the clinical significance of combined detection of CA125, CA153 and TSGF in breast cancer. Methods: Serum levels of CA125, CA153 and TSGF in 52 cases of breast cancer and 30 healthy people were detected by enzyme-linked immunosorbent assay. Results: The positive rates of CA125, CA153 and TSGF in patients with breast cancer were significantly higher than those in healthy individuals. The positive rates of combined detection of the three were significantly higher than those of any single test. The levels of CA125, CA153 and TSGF in patients with advanced breast cancer were significantly higher than those in early patients. Conclusion: The combined detection of CA125, CA153 and TSGF has certain significance for the early diagnosis, treatment and prognosis of breast cancer.